Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.39 |
| ▸ | KIF11 | P52732 | 2/20 | 0.39 |
| ▸ | MAPT | P10636 | 2/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.37 |
| ▸ | GAA | P10253 | 2/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.37 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.37 |
| ▸ | CA12 | O43570 | 1/20 | 0.36 |
| ▸ | CA1 | P00915 | 1/20 | 0.36 |
| ▸ | CA2 | P00918 | 1/20 | 0.36 |
| ▸ | CA7 | P43166 | 1/20 | 0.36 |
| ▸ | CA9 | Q16790 | 1/20 | 0.36 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.36 |
| ▸ | MEN1 | O00255 | 2/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.36 |
| ▸ | THRB | P10828 | 1/20 | 0.36 |
| ▸ | NPC1 | O15118 | 2/20 | 0.35 |
| ▸ | RAB9A | P51151 | 2/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5037971 | 0.84 | TRPA1 (0.40) | ALDH1A1SMN1; SMN2L3MBTL1TRPA1FFAR1 | |
| SCHEMBL7091860 | 0.83 | MAPT (0.42) | ALDH1A1MAPTKMT2AGAASMN1; SMN2 | |
| SCHEMBL7096863 | 0.81 | ESR1 (0.35) | ALDH1A1MAPK1CYP3A4RAB9ALMNA | |
| SCHEMBL26507116 | 0.78 | NR3C2 (0.40) | KMT2ASMN1; SMN2MEN1KDM4EPOLB | |
| SCHEMBL30108108 | 0.78 | NR3C2 (0.40) | KMT2ASMN1; SMN2MEN1KDM4EPOLB | |
| SCHEMBL7095297 | 0.78 | MEN1 (0.48) | ALDH1A1MAPTKMT2AGAASMN1; SMN2 | |
| SCHEMBL27600931 | 0.78 | CA4 (0.46) | ALDH1A1KMT2ACA12CA1CA2 | |
| SCHEMBL7095778 | 0.77 | LMNA (0.42) | ALDH1A1MAPTKMT2AGAASMN1; SMN2 | |
| SCHEMBL5236553 | 0.77 | CA4 (0.40) | ALDH1A1MAPTKMT2ASMN1; SMN2MAPK1 | |
| SCHEMBL7148596 | 0.76 | CA12 (0.39) | CA12CA1CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250353874-A1 | GLUCOCORTICOID RECEPTOR AGONISTS | LILLY CO ELI (US) | 2025-11-20 | — | — | US | disclosed |
| US-12404298-B2 | Glucocorticoid receptor agonists | ELI LILLY AND COMPANY (US) | 2025-09-02 | — | — | US | disclosed |
| EP-4314004-B1 | CARBOXY SUBSTITUTED GLUCOCORTICOID RECEPTOR AGONISTS | LILLY CO ELI (US) | 2025-01-22 | — | — | EP | disclosed |
| US-12162905-B2 | Carboxy substituted glucocorticoid receptor agonists | ELI LILLY AND COMPANY (US) | 2024-12-10 | — | — | US | disclosed |
| EP-4314005-A1 | GLUCOCORTICOID RECEPTOR AGONISTS | Eli Lilly and Company (US) | 2024-02-07 | — | — | EP | disclosed |
| EP-4314004-A1 | CARBOXY SUBSTITUTED GLUCOCORTICOID RECEPTOR AGONISTS | Eli Lilly and Company (US) | 2024-02-07 | — | — | EP | disclosed |
| US-20240018182-A1 | GLUCOCORTICOID RECEPTOR AGONISTS | ELI LILLY AND COMPANY | 2024-01-18 | — | — | US | disclosed |
| US-20240018182-A1 | GLUCOCORTICOID RECEPTOR AGONISTS | ELI LILLY AND COMPANY | 2024-01-18 | — | — | US | disclosed |
| US-20240018182-A1 | GLUCOCORTICOID RECEPTOR AGONISTS | ELI LILLY AND COMPANY | 2024-01-18 | — | — | US | disclosed |
| CN-117043172-A | Glucocorticoid receptor agonists | 伊莱利利公司 | 2023-11-10 | — | — | CN | disclosed |
| US-11787834-B2 | Glucocorticoid receptor agonists | ELI LILLY AND COMPANY (US) | 2023-10-17 | — | — | US | disclosed |
| CN-116888137-A | Carboxy substituted glucocorticoid receptor agonists | 伊莱利利公司 | 2023-10-13 | — | — | CN | disclosed |
| US-20230227493-A1 | CARBOXY SUBSTITUTED GLUCOCORTICOID RECEPTOR AGONISTS | ELI LILLY AND COMPANY | 2023-07-20 | — | — | US | disclosed |
| US-20230227493-A1 | CARBOXY SUBSTITUTED GLUCOCORTICOID RECEPTOR AGONISTS | ELI LILLY AND COMPANY | 2023-07-20 | — | — | US | disclosed |
| US-11618767-B2 | Carboxy substituted glucocorticoid receptor agonists | ELI LILLY AND COMPANY (US) | 2023-04-04 | — | — | US | disclosed |
| US-20220324904-A1 | GLUCOCORTICOID RECEPTOR AGONISTS | ELI LILLY AND COMPANY | 2022-10-13 | — | — | US | disclosed |
| WO-2022204099-A1 | CARBOXY SUBSTITUTED GLUCOCORTICOID RECEPTOR AGONISTS | ELI LILLY AND COMPANY (US) | 2022-09-29 | — | — | WO | disclosed |
| WO-2022204108-A1 | GLUCOCORTICOID RECEPTOR AGONISTS | ELI LILLY AND COMPANY (US) | 2022-09-29 | — | — | WO | disclosed |
| US-20220306681-A1 | CARBOXY SUBSTITUTED GLUCOCORTICOID RECEPTOR AGONISTS | ELI LILLY AND COMPANY | 2022-09-29 | — | — | US | disclosed |
| US-20220306681-A1 | CARBOXY SUBSTITUTED GLUCOCORTICOID RECEPTOR AGONISTS | ELI LILLY AND COMPANY | 2022-09-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (9 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230227493-A1 | CARBOXY SUBSTITUTED GLUCOCORTICOID RECEPTOR AGONISTS | NR3C1, MC2R, NR3C2 | ALDH1A1 2971/4885KIF11 4482/4885MAPT 4721/4885 |
| US-20220306681-A1 | CARBOXY SUBSTITUTED GLUCOCORTICOID RECEPTOR AGONISTS | NR3C1, MC2R, NR3C2 | ALDH1A1 2971/4885KIF11 4482/4885MAPT 4721/4885 |
| US-12404298-B2 | Glucocorticoid receptor agonists | NR3C1, NR3C2, MC2R | ALDH1A1 3227/4885KIF11 4147/4885MAPT 3892/4885 |
| US-20240018182-A1 | GLUCOCORTICOID RECEPTOR AGONISTS | NR3C1, NR3C2, MC2R | ALDH1A1 3227/4885KIF11 4147/4885MAPT 3892/4885 |
| US-20250353874-A1 | GLUCOCORTICOID RECEPTOR AGONISTS | NR3C1, NR3C2, MC2R | ALDH1A1 3227/4885KIF11 4147/4885MAPT 3892/4885 |
| US-11787834-B2 | Glucocorticoid receptor agonists | NR3C1, NR3C2, MC2R | ALDH1A1 3227/4885KIF11 4147/4885MAPT 3892/4885 |
| US-20220324904-A1 | GLUCOCORTICOID RECEPTOR AGONISTS | NR3C1, NR3C2, MC2R | ALDH1A1 3227/4885KIF11 4147/4885MAPT 3892/4885 |
| US-11618767-B2 | Carboxy substituted glucocorticoid receptor agonists | NR3C1, MC2R, NR3C2 | ALDH1A1 2971/4885KIF11 4482/4885MAPT 4721/4885 |
| US-12162905-B2 | Carboxy substituted glucocorticoid receptor agonists | NR3C1, MC2R, NR3C2 | ALDH1A1 2971/4885KIF11 4482/4885MAPT 4721/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.